logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Anastrozole+fulvestrant tops anastrozole alone in HR+ advanced breast cancer: meta-analysis

Better efficacy comes at the expense of more adverse effects.